AFib burden February 20, 2020 01:22PM |
Registered: 6 years ago Posts: 922 |
Re: AFib burden February 20, 2020 04:26PM |
Admin Registered: 6 years ago Posts: 5,362 |
Re: AFib burden February 20, 2020 10:40PM |
Registered: 9 years ago Posts: 182 |
Re: AFib burden February 21, 2020 12:30AM |
Admin Registered: 6 years ago Posts: 5,362 |
Quote
Findings In a cohort study of 1965 adults with paroxysmal atrial fibrillation, a greater burden of atrial fibrillation (≥11%) on 14-day noninvasive, continuous electrocardiographic monitoring was associated with a significantly higher rate of thromboembolism while not taking anticoagulation vs a lower burden.
Re: AFib burden February 21, 2020 12:35AM |
Registered: 6 years ago Posts: 922 |
Re: AFib burden February 21, 2020 07:57AM |
Registered: 11 years ago Posts: 4,232 |
Quote
Limitations
Our analysis had several limitations. Information on the exact reasons for undergoing arrhythmia monitoring and for not receiving anticoagulation was unavailable. Given the number of events, we had limited power to determine thromboembolic risk at more granular cutoffs of atrial fibrillation burden, but our data suggested a threshold of approximately 11% as meaningful in the overall cohort and across age, sex, and subgroups without diabetes, chronic kidney disease, and hypertension. We were underpowered to evaluate the association of atrial fibrillation burden with thromboembolism in this subset of patients with a CHA2DS2-VASc score of 0 or 1. Patients in the highest tertile of atrial fibrillation burden were more likely to receive anticoagulation, which led to modestly fewer person-years while not taking anticoagulation in this subgroup (586) than those in the first (690) or second (639) tertiles, but this would bias the association between atrial fibrillation burden and thromboembolism toward the null. While a greater burden of atrial fibrillation could theoretically lead to longer periods of blood stasis, the promotion of thrombus generation, and the development of worsening of certain stroke risk factors (eg, heart failure or impaired kidney function), we were unable to determine if the burden of atrial fibrillation is a marker of risk or causative. Although we studied primarily insured adults in California, our results are likely to be generalizable to other populations and practice settings. Our analysis that examined any intermittent periods of time not taking anticoagulation during follow-up as a continuous period for an individual patient was based on the assumption of a constant hazard of the outcome, which may not be true; however, we did not find any evidence of violation of the proportionality assumption. Our continuous electrocardiographic monitoring strategy was only up to 14 days, so we were unable to evaluate the potential value of longer (or shorter) periods to characterize the burden of atrial fibrillation. Finally, as stroke risk factors can accumulate over time in patients, risk stratification is a dynamic process and further study is needed to evaluate the incremental utility of repeated episodes of characterizing atrial fibrillation burden.
Re: AFib burden February 21, 2020 08:52AM |
Registered: 9 years ago Posts: 182 |
Quote
Carey
From your study:
Findings In a cohort study of 1965 adults with paroxysmal atrial fibrillation, a greater burden of atrial fibrillation (≥11%) on 14-day noninvasive, continuous electrocardiographic monitoring was associated with a significantly higher rate of thromboembolism while not taking anticoagulation vs a lower burden.
These are completely expected results.
Re: AFib burden February 21, 2020 08:58AM |
Registered: 9 years ago Posts: 182 |
Re: AFib burden February 21, 2020 09:35AM |
Registered: 11 years ago Posts: 4,232 |
Re: AFib burden February 21, 2020 10:21AM |
Admin Registered: 6 years ago Posts: 5,362 |
Re: AFib burden February 21, 2020 10:29AM |
Admin Registered: 6 years ago Posts: 5,362 |
Quote
safib
That is incorrect. The results are startling in that they suggest (i) there is a quantified risk associated with afib independent of comorbidities; and (ii) the risk is associated with the total burden and not with the longest duration.
Re: AFib burden February 21, 2020 11:28AM |
Registered: 9 years ago Posts: 182 |
Quote
Carey
Mainly, I think slicing and dicing numbers so finely just to avoid taking an anticoagulant is a waste of time and an unnecessary risk.
Re: AFib burden February 21, 2020 02:31PM |
Registered: 10 years ago Posts: 1,748 |
Re: AFib burden February 21, 2020 03:56PM |
Registered: 6 years ago Posts: 922 |
Quote
Carey
I don't think there are solid answers to your questions except maybe #4. There's conflicting evidence on how long it takes for clots to begin to form during an afib episode, with one study showing it's only minutes. That study may be an outlier because the study population was older and sicker, but still, nobody has a firm answer to the question. So if I were you I would take the Pradaxa when an episode begins. That was my EP's answer when I was using Pradaxa as a PIP.
Re: AFib burden February 21, 2020 09:07PM |
Registered: 9 years ago Posts: 75 |
Re: AFib burden February 21, 2020 09:09PM |
Admin Registered: 6 years ago Posts: 5,362 |
Quote
safib
Again, this is not correct. If the results hold up, this means that a potentially large population of those with paroxysmal afib may not have to be anticoagulated for life, including those with CHADs of 2 or larger. There are many issues with anticoagulation including, cost, compliance, bleed risk, and surgical complications. Although the study is far from definitive, it is wrong to assert this type of research is a "waste of time", and your view is not held by the research community where further risk quantification is a high priority.
Re: AFib burden February 22, 2020 02:39AM |
Registered: 6 years ago Posts: 922 |
Quote
SteveCarr
And that is the answer to anyone who (sometimes somewhat critically even) asks why anyone would bother going through major efforts to find underlying dietary and/or lifestyle solutions to their afib rather than take an "easier" way out : getting rid of the underlying cause is also extremely likely to be yielding other major benefits beyond "mere" afib remission.
Re: AFib burden February 25, 2020 04:40PM |
Registered: 9 years ago Posts: 182 |
Quote
Carey
Again, this is not correct. If the results hold up, this means that a potentially large population of those with paroxysmal afib may not have to be anticoagulated for life, including those with CHADs of 2 or larger. There are many issues with anticoagulation including, cost, compliance, bleed risk, and surgical complications. Although the study is far from definitive, it is wrong to assert this type of research is a "waste of time", and your view is not held by the research community where further risk quantification is a high priority.
"Not correct" in your opinion. I don't think you can summarily declare my statement incorrect.
My point is exactly what you said: "If the results hold up". The thing is, I don't think they will. But we'll see.